Patents by Inventor Mettu Ravinder

Mettu Ravinder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for preparation of indolizine based derivatives as potential phosphodiestrase 3 (PDE3) inhibitors
    Patent number: 9562045
    Abstract: The present invention provides compounds of general formula 1 useful as potential phosphodiesterase3 (PDE3) inhibitory agents and a process for the preparation thereof. The derivatives of formula 1 can be employed as therapeutics in human and veterinary medicine, where they can be used, for example, for the treatment and prophylaxis of the following diseases: heart failure, dilated cardiomyopathy, platelet inhibitors, cancer and obstructive pulmonary diseases.
    Type: Grant
    Filed: January 19, 2016
    Date of Patent: February 7, 2017
    Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Budde Mahendar, Saidulu Mattapally, Mettu Ravinder, Sanjay Kumar Banerjee, Vaidya Jayathirtha Rao
  • Pyridopyrimidine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof
    Patent number: 9505760
    Abstract: The present invention provides compounds of formula 1 as potential phosphodiesterase3 (PDE3) inhibitory agents and a process for the preparation thereof. The derivatives of formula 1 can be employed as therapeutics in human and veterinary medicine, where they can be used, for the treatment and prophylaxis of the following diseases: heart failure, dilated cardiomyopathy, platelet inhibitors, cancer and obstructive pulmonary diseases.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: November 29, 2016
    Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Budde Mahendar, Saidulu Mattapally, Mettu Ravinder, Sanjay Kumar Banerjee, Vaidya Jayathirtha Rao
  • PYRIDOPYRIMIDINE BASED DERIVATIVES AS POTENTIAL PHOSPHODIESTERASE 3 (PDE3) INHIBITORS AND A PROCESS FOR THE PREPARATION THEREOF
    Publication number: 20160194319
    Abstract: The invention relates to a process for the synthesis of pyridopyrimidine derivatives, which work as PDE3 inhibitors.
    Type: Application
    Filed: January 6, 2016
    Publication date: July 7, 2016
    Inventors: Budde MAHENDAR, Saidulu MATTAPALLY, Mettu RAVINDER, Sanjay Kumar BANERJEE, Vaidya Jayathirtha RAO
  • PROCESS FOR PREPARATION OF INDOLIZINE BASED DERIVATIVES AS POTENTIAL PHOSPHODIESTRASE 3 (PDE3) INHIBITORS
    Publication number: 20160159792
    Abstract: The present invention provides compounds of general formula 1 useful as potential phosphodiesterase3 (PDE3) inhibitory agents and a process for the preparation thereof. The derivatives of formula 1 can be employed as therapeutics in human and veterinary medicine, where they can be used, for example, for the treatment and prophylaxis of the following diseases: heart failure, dilated cardiomyopathy, platelet inhibitors, cancer and obstructive pulmonary diseases.
    Type: Application
    Filed: January 19, 2016
    Publication date: June 9, 2016
    Inventors: Budde MAHENDAR, Saidulu MATTAPALLY, Mettu RAVINDER, Sanjay Kumar BANERJEE, Vaidya Jayathirtha RAO
  • Indolizinone based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof
    Patent number: 9249139
    Abstract: The present invention provides compounds of general formula A useful as potential phosphodiesterase3 (PDE3) inhibitory agents and a process for the preparation thereof. The derivatives of formula A can be employed as therapeutics in human and veterinary medicine, where they can be used, for example, for the treatment and prophylaxis of the following diseases: heart failure, dilated cardiomyopathy, platelet inhibitors, cancer and obstructive pulmonary diseases.
    Type: Grant
    Filed: January 30, 2014
    Date of Patent: February 2, 2016
    Assignee: Council of Scientific & Industrial Research
    Inventors: Budde Mahendar, Saidulu Mattapally, Mettu Ravinder, Sanjay Kumar Banerjee, Vaidya Jayathirtha Rao
  • Pyridopyrimidine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof
    Patent number: 9242982
    Abstract: The present invention provides compounds of formula 1 as potential phosphodiesterase3 (PDE3) inhibitory agents and a process for the preparation thereof. The derivatives of formula 1 can be employed as therapeutics in human and veterinary medicine, where they can be used, for the treatment and prophylaxis of the following diseases: heart failure, dilated cardiomyopathy, platelet inhibitors, cancer and obstructive pulmonary diseases.
    Type: Grant
    Filed: January 30, 2014
    Date of Patent: January 26, 2016
    Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Budde Mahendar, Saidulu Mattapally, Mettu Ravinder, Sanjay Kumar Banerjee, Vaidya Jayathirtha Rao
  • INDOLIZINONE BASED DERIVATIVES AS POTENTIAL PHOSPHODIESTERASE 3 (PDE3) INHIBITORS AND A PROCESS FOR THE PREPARATION THEREOF
    Publication number: 20140296530
    Abstract: The present invention provides compounds of general formula A useful as potential phosphodiesterase3 (PDE3) inhibitory agents and a process for the preparation thereof. The derivatives of formula A can be employed as therapeutics in human and veterinary medicine, where they can be used, for example, for the treatment and prophylaxis of the following diseases: heart failure, dilated cardiomyopathy, platelet inhibitors, cancer and obstructive pulmonary diseases.
    Type: Application
    Filed: January 30, 2014
    Publication date: October 2, 2014
    Applicant: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Budde MAHENDAR, Saidulu MATTAPALLY, Mettu RAVINDER, Sanjay Kumar BANERJEE, Vaidya Jayathirtha RAO
  • PYRIDOPYRIMIDINE BASED DERIVATIVES AS POTENTIAL PHOSPHODIESTERASE 3 (PDE3) INHIBITORS AND A PROCESS FOR THE PREPARATION THEREOF
    Publication number: 20140221651
    Abstract: The present invention provides compounds of formula 1 as potential phosphodiesterase3 (PDE3) inhibitory agents and a process for the preparation thereof. The derivatives of formula 1 can be employed as therapeutics in human and veterinary medicine, where they can be used, for the treatment and prophylaxis of the following diseases: heart failure, dilated cardiomyopathy, platelet inhibitors, cancer and obstructive pulmonary diseases.
    Type: Application
    Filed: January 30, 2014
    Publication date: August 7, 2014
    Applicant: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Budde MAHENDAR, Saidulu MATTAPALLY, Mettu RAVINDER, Sanjay Kumar BANERJEE, Vaidya Jayathirtha RAO
  • Antimalarial Baylis-Hillman adducts and a process for the preparation thereof
    Patent number: 7666883
    Abstract: The present invention is directed towards the synthesis of novel and new chloropyridine skeleton based compounds and these are Bayllis Hillman adducts having a remarkable in vitro anti-malarial activity. These compounds have been found to possess anti-malarial activity against chloroquine sensitive and chloroquine resistant Plasmodium falciparum. The anti-malarial compounds of the present invention inhibit the mature schizonts in vitro.
    Type: Grant
    Filed: March 3, 2006
    Date of Patent: February 23, 2010
    Assignee: Council of Scientific and Industrial Research
    Inventors: Puli Narender, Banda Gangadasu, Uppalanchi Srinivas, Mettu Ravinder, Sriramoju Bharat Kumar, Chilukuri Ramesh, Vaidya Jayathirtha Rao, Janaswamy Madhusudhan Rao
  • Novel antimalarial baylis-hillman adducts and a process for the preparation thereof
    Publication number: 20070117822
    Abstract: The present invention is directed towards the synthesis of novel and new chloropyridine skeleton based compounds and these are Bayllis Hillman adducts having a remarkable in vitro anti-malarial activity. These compounds have been found to possess anti-malarial activity against chloroquine sensitive and chloroquine resistant Plasmodium falciparum. The anti-malarial compounds of the present invention inhibit the mature schizonts in vitro.
    Type: Application
    Filed: March 3, 2006
    Publication date: May 24, 2007
    Inventors: Puli Narender, Banda Gangadasu, Uppalanchi Srinivas, Mettu Ravinder, Sriramoju Kumar, Chilukuri Ramesh, Vaidya Rao, Janaswamy Rao